As of 2024-07-27, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (0.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.18 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -100.4%.
The range of the Relative Valuation is (2.59) - 2.62 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 30.1x - 31.2x | 30.6x |
| Fair Price | (2.59) - 2.62 | (0.03) |
| Upside | -141.8% - -57.6% | -100.4% |
| Date | P/E |
| 2024-07-26 | -73.61 |
| 2024-07-25 | -73.26 |
| 2024-07-24 | -73.49 |
| 2024-07-23 | -75.04 |
| 2024-07-22 | -75.52 |
| 2024-07-19 | -72.78 |
| 2024-07-18 | -72.30 |
| 2024-07-17 | -74.09 |
| 2024-07-16 | -74.21 |
| 2024-07-15 | -71.71 |
| 2024-07-12 | -70.52 |
| 2024-07-11 | -69.09 |
| 2024-07-10 | -62.06 |
| 2024-07-09 | -63.37 |
| 2024-07-08 | -62.77 |
| 2024-07-05 | -62.42 |
| 2024-07-03 | -63.85 |
| 2024-07-02 | -62.77 |
| 2024-07-01 | -66.47 |
| 2024-06-28 | -67.30 |
| 2024-06-27 | -69.21 |
| 2024-06-26 | -71.23 |
| 2024-06-25 | -73.14 |
| 2024-06-24 | -71.23 |
| 2024-06-21 | -72.90 |
| 2024-06-20 | -71.17 |
| 2024-06-18 | -75.52 |
| 2024-06-17 | -75.64 |
| 2024-06-14 | -74.33 |
| 2024-06-13 | -77.43 |
| 2024-06-12 | -70.52 |
| 2024-06-11 | -71.35 |
| 2024-06-10 | -71.23 |
| 2024-06-07 | -72.90 |
| 2024-06-06 | -74.69 |
| 2024-06-05 | -60.15 |
| 2024-06-04 | -59.92 |
| 2024-06-03 | -60.99 |
| 2024-05-31 | -60.87 |
| 2024-05-30 | -59.68 |
| 2024-05-29 | -58.60 |
| 2024-05-28 | -59.32 |
| 2024-05-24 | -62.30 |
| 2024-05-23 | -58.49 |
| 2024-05-22 | -61.23 |
| 2024-05-21 | -60.87 |
| 2024-05-20 | -62.77 |
| 2024-05-17 | -65.28 |
| 2024-05-16 | -66.47 |
| 2024-05-15 | -63.85 |